In vivo relevance of bystander and non-targeted effects
46No. 880 in all physics · No. 41 in Medical and Radiation Physics
Determine whether bystander signalling, genomic instability and abscopal responses change organ-level risk at doses below 10 rad in vivo, relative to the prediction from directly hit cells alone. Required: dose range, signalling distance in tissue, and persistence. An answer is a quantified modification factor or a demonstration that it is negligible.
What would settle it
In vivo experiments with spatially restricted irradiation, such as microbeam or partial-body exposure, measuring effects in unirradiated tissue at low dose.
No solutions, ideas or subproblems yet.
See also
- Related Why narrow beams spare tissue that wide beams destroy
- Related Does risk stay linear below 10 rad?
Details, signature and history
- Kind
- Well-posed question
- Answer
- Yes no
- Posed
- 1992
- Topic review
- Brenner et al., Cancer risks attributable to low doses of ionizing radiation: assessing what we really know, Proceedings of the National Academy of Sciences, 2003. Link
- Record
- Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor
Proof
- Fingerprint
- 7a2b342b400c…
- Public log
- Entry 1,700, in checkpoint 2,123
- In the log by
- Block 969,698, 2026-10-03
This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.
Comments (0)
Comments are not records: they are not signed, stamped or logged. How comments work
No comments yet.
Sign in to comment.